Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and the gut

Overview of attention for article published in Frontiers in immunology, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 32,885 followers.

Will #LongCovid and other diseases come down to HLA gene therapy? I can forsee an mrna for #VaccineInjuries ... but I'd be afraid to take it? #POTS #MECFS https://t.co/LUa7Z1ZWqQ https://t.co/6N6LY0Uf4x

04 May 2024

Reply Repost Favourite

@medtechlyfe Relevant to your interests: https://t.co/6oTYMSd38j

13 Oct 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and t…

10 Oct 2023

Reply Repost Favourite

New Research: Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and the gut: Human leukocyte antigen (HLA) genes are associated with more diseases than any other region of the genome. Highly… #immunology

26 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.